Samsara-Biocapital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
37
Total Value
560807077
Accession Number
0001415889-25-013106
Form Type
13F-HR
Manager Name
Samsara-Biocapital
Data Enrichment
95% identified
35 identified2 unidentified

Holdings

37 positions • $560.8M total value
Manager:
Search and click to pin securities to the top
Page 2 of 2
Surrozen, Inc./DE
Shares:241.4K
Value:$2.8M
% of Portfolio:0.5% ($2.8M/$560.8M)
Abivax S.A.
Shares:425.0K
Value:$2.7M
% of Portfolio:0.5% ($2.7M/$560.8M)
SUTRO BIOPHARMA, INC.
Shares:2.2M
Value:$1.4M
% of Portfolio:0.3% ($1.4M/$560.8M)
Inozyme Pharma, Inc.
Shares:1.6M
Value:$1.4M
% of Portfolio:0.3% ($1.4M/$560.8M)
Artiva Biotherapeutics, Inc.
Shares:291.7K
Value:$875.0K
% of Portfolio:0.2% ($875.0K/$560.8M)
Tango Therapeutics, Inc.
Shares:630.0K
Value:$863.1K
% of Portfolio:0.2% ($863.1K/$560.8M)
Prime Medicine, Inc.
Shares:405.2K
Value:$806.4K
% of Portfolio:0.1% ($806.4K/$560.8M)
LEAP THERAPEUTICS, INC.
Shares:2.4M
Value:$745.2K
% of Portfolio:0.1% ($745.2K/$560.8M)
HilleVax, Inc.
Shares:399.6K
Value:$579.5K
% of Portfolio:0.1% ($579.5K/$560.8M)
Terns Pharmaceuticals, Inc.
Shares:202.3K
Value:$558.5K
% of Portfolio:0.1% ($558.5K/$560.8M)
Bolt Biotherapeutics, Inc.
Shares:1.0M
Value:$419.7K
% of Portfolio:0.1% ($419.7K/$560.8M)
CURIS INC
Shares:185.9K
Value:$390.5K
% of Portfolio:0.1% ($390.5K/$560.8M)
Lyra Therapeutics, Inc.
Shares:1.4M
Value:$175.6K
% of Portfolio:0.0% ($175.6K/$560.8M)
Kronos Bio, Inc.
Shares:78.1K
Value:$64.5K
% of Portfolio:0.0% ($64.5K/$560.8M)
67080N119
Shares:133.3K
Value:$42.7K
% of Portfolio:0.0% ($42.7K/$560.8M)
Allakos Inc.
Shares:172.1K
Value:$39.2K
% of Portfolio:0.0% ($39.2K/$560.8M)
86889P117
Shares:100.0K
Value:$3.0K
% of Portfolio:0.0% ($3.0K/$560.8M)